Genome & Company (KOSDAQ:314130)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,910.00
+55.00 (1.93%)
At close: Oct 28, 2025

Genome & Company Market Cap

Genome & Company has a market cap or net worth of 99.94 billion as of October 30, 2025. Its market cap has decreased by -9.44% in one year.

Market Cap
99.94B
Enterprise Value
94.00B
Revenue
24.02B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,910.00

Market Cap Chart

Since December 26, 2018, Genome & Company's market cap has increased from 71.88B to 99.94B, an increase of 39.04%. That is a compound annual growth rate of 4.93%.

History

DateMarket Cap% Change
Oct 30, 202599.94B17.29%
Dec 30, 202485.21B-51.64%
Dec 28, 2023176.21B-28.34%
Dec 29, 2022245.90B-47.55%
Dec 30, 2021468.83B-55.28%
Dec 30, 20201.05T224.28%
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 26, 2018 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition